ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

THRX Theseus Pharmaceuticals Inc

4.06
0.00 (0.00%)
Pre Market
Last Updated: 19:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Theseus Pharmaceuticals Inc THRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 4.06 19:00:00
Open Price Low Price High Price Close Price Previous Close
4.06
more quote information »

Recent News

Date Time Source Heading
2/26/202408:00EDGAR2Form 15-12G - Securities registration termination [Section..
2/15/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/14/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202413:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
2/14/202413:22EDGAR2Form POS AM - Post-Effective amendments for registration..
2/14/202409:44EDGAR2Form 8-K - Current report
2/14/202409:35EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
2/14/202407:30PRNUSTheseus Pharmaceuticals Announces Closing of Tender Offer
2/13/202411:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202416:21EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2/07/202416:15EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
1/30/202407:52EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
1/30/202407:23EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
1/30/202407:00BWConcentra Announces Calculation of Additional Price Per..
1/10/202408:47EDGAR2Form SC 14D9 - Solicitation, recommendation statements
1/10/202407:51EDGAR2Form SC TO-T - Tender offer statement by Third Party
12/22/202305:52EDGAR2Form SC14D9C - Written communication relating to third party..
12/22/202305:36EDGAR2Form 8-K - Current report
12/22/202305:30PRNUSTheseus Pharmaceuticals Enters into Agreement to Be Acquired..
12/04/202305:30EDGAR2Form 8-K - Current report
11/27/202305:37EDGAR2Form 8-K - Current report
11/27/202305:30PRNUSTheseus Pharmaceuticals Confirms Receipt of Unsolicited..
11/24/202315:23EDGAR2Form SC 13D/A - General statement of acquisition of..
11/17/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/15/202306:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
11/13/202315:05PRNUSTheseus Pharmaceuticals Announces Process to Explore..
11/07/202315:05PRNUSTheseus Pharmaceuticals to Participate in the Stifel 2023..
11/07/202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202315:13EDGAR2Form 8-K - Current report
8/10/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202306:05EDGAR2Form 8-K - Current report
8/10/202306:00PRNUSTheseus Pharmaceuticals Announces Business Highlights and..
7/19/202313:41EDGAR2Form SC 13D/A - General statement of acquisition of..
7/14/202306:51IHMARKETNEWSFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..
7/13/202315:08EDGAR2Form 8-K - Current report
7/13/202315:05PRNUSTheseus Pharmaceuticals to Discontinue Enrollment in Phase..
5/31/202306:00PRNUSTheseus Pharmaceuticals to Participate in the Jefferies..
5/25/202316:01PRNUSTheseus Pharmaceuticals Reports Initial Dose Escalation Data..
5/11/202306:00PRNUSTheseus Pharmaceuticals Announces Business Highlights and..

Your Recent History

Delayed Upgrade Clock